WILLIAM CONKLING

CIK 1852018 · Chief Commercial Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.51M

Companies

5

Total Filings

28

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IDT Director 673 $54.63 $36.8K $0 1 2026-06-11
TARA Chief Commercial Officer 69,992 $3.90 $273.0K $0 3 2026-06-03
Rafael Holdings, Inc. (RFL.WS) Delisted Chief Executive Officer 564,455 $0.01 $8.0K $0 1 2025-04-24
RFL Chief Executive Officer 537,001 $2.24 $1.20M $0 15 2025-03-25
Cyclo Therapeutics, Inc. (CYTHW) Delisted Director 77,884 $0.03 $2.5K $0 8 2025-03-03

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-09-22 RFL Tax (F) −13,669 -$30.1K EDGAR
2023-08-22 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +2,449 $0 EDGAR
2023-06-22 RFL Tax (F) −15,170 -$32.6K EDGAR
2023-06-07 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) $0 EDGAR
2023-03-23 RFL Tax (F) −15,625 -$26.1K EDGAR
2022-12-23 RFL Tax (F) −56,149 -$98.8K EDGAR
2022-02-03 RFL Grant (A) +623,732 $0 EDGAR
2021-04-19 RFL Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.